ArticleToxicology and applied pharmacology2022

The myosin II inhibitor, blebbistatin, ameliorates pulmonary endothelial barrier dysfunction in acute lung injury induced by LPS via NMMHC IIA/Wnt5a/β-catenin pathway.

Jiazhi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.